Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $7 | $3 | $17 |
| % Growth | 181.4% | 136.4% | -82.4% | – |
| Cost of Goods Sold | $19 | $10 | $32 | $33 |
| Gross Profit | $1 | -$3 | -$2 | -$16 |
| % Margin | 5% | -43.8% | -63% | -90.7% |
| R&D Expenses | $0 | $3 | $28 | $37 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10 | $8 | $48 | $64 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$9 | $0 | -$55 | -$4 |
| Operating Expenses | $1 | $11 | $21 | $96 |
| Operating Income | -$0 | -$14 | -$23 | -$116 |
| % Margin | -0.3% | -200.5% | -757.9% | -671.2% |
| Other Income/Exp. Net | -$4 | $3 | $52 | -$2 |
| Pre-Tax Income | -$5 | -$12 | $29 | -$118 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$82 | -$40 | -$118 |
| % Margin | -47.4% | -1,139.9% | -1,307% | -681.7% |
| EPS | -0.32 | -2.81 | -1.39 | -4.11 |
| % Growth | 88.6% | -102.2% | 66.2% | – |
| EPS Diluted | -0.32 | -2.81 | -1.39 | -4.11 |
| Weighted Avg Shares Out | 30 | 29 | 28 | 29 |
| Weighted Avg Shares Out Dil | 30 | 29 | 28 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $3 | $1 | $0 |
| Interest Expense | $6 | $6 | $5 | $6 |
| Depreciation & Amortization | $1 | $1 | $1 | $7 |
| EBITDA | $2 | -$5 | $35 | -$105 |
| % Margin | 11.2% | -74.4% | 1,161.5% | -608.9% |